UK markets close in 3 hours 46 minutes

Maravai LifeSciences Holdings, Inc. (MAR.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
6.40-0.05 (-0.78%)
As of 08:05AM CEST. Market open.
Full screen
Previous close6.45
Open6.40
Bid6.35 x N/A
Ask6.40 x N/A
Day's range6.40 - 6.40
52-week range4.20 - 12.20
Volume500
Avg. volume17
Market cap1.604B
Beta (5Y monthly)0.06
PE ratio (TTM)N/A
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Insider Monkey

    Here’s Why RGAIA Considers Maravai LifeSciences Holdings’ (MRVI) Margin Structure as the Best

    RGA Investment Advisors, an investment management company released its first quarter 2024 investor letter. A copy of the letter can be downloaded here. Strong economic growth combined with frustratingly resilient inflation defined the macroeconomic environment in the first quarter. The large caps outperformed their smaller counterparts in Q1. It may be the result of continued […]

  • GuruFocus.com

    Steven Cohen's Strategic Acquisition in Maravai LifeSciences Holdings Inc

    On June 7, 2024, Steven Cohen (Trades, Portfolio)'s firm made a significant addition to its investment portfolio by acquiring 6,647,015 shares of Maravai LifeSciences Holdings Inc (NASDAQ:MRVI). This move has increased the firm's stake in Maravai LifeSciences to 5.00% of the total shares outstanding, reflecting a strategic position with a 0.14% portfolio weight and a trade impact of 0.11%. Steven A. Cohen, Chairman and CEO of Point72, a prominent investment advisor, has a distinguished career in the financial markets.

  • Zacks

    Maravai (MRVI) Advances in RNA Research With New Collaboration

    Per Maravai LifeSciences (MRVI) management, this development by TriLink is set to advance nucleic acid-based therapies.